SEC Comment Letter for ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221) (ARTL) — Jan 21, 2020
ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221)
Date: Jan. 21, 2020 · CIK: 0001621221 · Accession: 0000000000-20-000515
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-235917
Letter
January 21, 2020 Gregory D. Gorgas Chief Executive Officer and President Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla, CA 92037 Re:Artelo Biosciences, Inc. Registration Statement on Form S-3 Filed January 15, 2020 File No. 333-235917 Dear Mr. Gorgas: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Katherine Bagley at (202) 551-2545 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Martin J. Waters
Show Raw Text
January 21, 2020
Gregory D. Gorgas
Chief Executive Officer and President
Artelo Biosciences, Inc.
888 Prospect Street, Suite 210
La Jolla, CA 92037
Re:Artelo Biosciences, Inc.
Registration Statement on Form S-3
Filed January 15, 2020
File No. 333-235917
Dear Mr. Gorgas:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Katherine Bagley at (202) 551-2545 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: Martin J. Waters